Saluda Medical

Saluda Medical is a commercial-stage medical device company that develops and commercializes advanced neuromodulation technologies for the treatment of chronic neurological conditions. The company's flagship product, the Evoke® System, is the first clinically validated, biomarker-based spinal cord stimulation (SCS) system that records Evoked Compound Action Potentials (ECAPs) to provide closed-loop, dose-controlled therapy in real-time. By sensing and measuring neural responses to stimulation, the Evoke® System automatically adjusts therapy to maintain consistent neural activation, aiming to improve pain relief outcomes and reduce the burden of manual programming for clinicians and patients. The company is actively expanding its commercial presence in the United States, Europe, and Australia.